Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiboost: MCC plus pertussis booster in adolescents
ISRCTN18766300Phase 4Completed
- Sponsor
- Health Protection Agency (HPA)
- Start
- Aug 2013
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01
Overview
Phase 4, randomised trial of Boostrix Polio, Adacel Polio, Meningococcal group C polysaccharide conjugate vaccine and Hib-MenC-TT in meningococcal disease and pertussis (8 arms), sponsored by Health Protection Agency (HPA). Primary endpoints: Meningococcal serogroup C-specific immune response and Pertussis-specific immune response. Started Aug 2013; status: completed.
02
Drugs
Boostrix PolioAdacel PolioMeningococcal group C polysaccharide conjugate vaccineHib-MenC-TT
03
Conditions
meningococcal diseasepertussis
Beyond the preview
Go deeper on ISRCTN18766300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18766300.